Literature DB >> 22148351

Structure of the stapled p53 peptide bound to Mdm2.

Sohee Baek1, Peter S Kutchukian, Gregory L Verdine, Robert Huber, Tad A Holak, Ki Won Lee, Grzegorz M Popowicz.   

Abstract

Mdm2 is a major negative regulator of the tumor suppressor p53 protein, a protein that plays a crucial role in maintaining genome integrity. Inactivation of p53 is the most prevalent defect in human cancers. Inhibitors of the Mdm2-p53 interaction that restore the functional p53 constitute potential nongenotoxic anticancer agents with a novel mode of action. We present here a 2.0 Å resolution structure of the Mdm2 protein with a bound stapled p53 peptide. Such peptides, which are conformationally and proteolytically stabilized with all-hydrocarbon staples, are an emerging class of biologics that are capable of disrupting protein-protein interactions and thus have broad therapeutic potential. The structure represents the first crystal structure of an i, i + 7 stapled peptide bound to its target and reveals that rather than acting solely as a passive conformational brace, a staple can intimately interact with the surface of a protein and augment the binding interface.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22148351     DOI: 10.1021/ja2090367

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  63 in total

Review 1.  Focusing on shared subpockets - new developments in fragment-based drug discovery.

Authors:  Eman M M Abdelraheem; Carlos J Camacho; Alexander Dömling
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

Review 2.  Targeting recognition surfaces on natural proteins with peptidic foldamers.

Authors:  James W Checco; Samuel H Gellman
Journal:  Curr Opin Struct Biol       Date:  2016-07-05       Impact factor: 6.809

3.  Identification of a Structural Determinant for Selective Targeting of HDMX.

Authors:  Yael Ben-Nun; Hyuk-Soo Seo; Edward P Harvey; Zachary J Hauseman; Thomas E Wales; Catherine E Newman; Ann M Cathcart; John R Engen; Sirano Dhe-Paganon; Loren D Walensky
Journal:  Structure       Date:  2020-04-30       Impact factor: 5.006

Review 4.  Targeting protein-protein interfaces using macrocyclic peptides.

Authors:  Meng Gao; Kui Cheng; Hang Yin
Journal:  Biopolymers       Date:  2015-07       Impact factor: 2.505

5.  Transient protein states in designing inhibitors of the MDM2-p53 interaction.

Authors:  Michal Bista; Siglinde Wolf; Kareem Khoury; Kaja Kowalska; Yijun Huang; Ewa Wrona; Marcelino Arciniega; Grzegorz M Popowicz; Tad A Holak; Alexander Dömling
Journal:  Structure       Date:  2013-10-24       Impact factor: 5.006

6.  Accelerating physical simulations of proteins by leveraging external knowledge.

Authors:  Alberto Perez; Joseph A Morrone; Ken A Dill
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2017-04-19

7.  Structure of the EmrE multidrug transporter and its use for inhibitor peptide design.

Authors:  Victor Ovchinnikov; Tracy A Stone; Charles M Deber; Martin Karplus
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-06       Impact factor: 11.205

Review 8.  Inhibition of α-helix-mediated protein-protein interactions using designed molecules.

Authors:  Valeria Azzarito; Kérya Long; Natasha S Murphy; Andrew J Wilson
Journal:  Nat Chem       Date:  2013-03       Impact factor: 24.427

9.  Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α.

Authors:  Dennis L Buckley; Jeffrey L Gustafson; Inge Van Molle; Anke G Roth; Hyun Seop Tae; Peter C Gareiss; William L Jorgensen; Alessio Ciulli; Craig M Crews
Journal:  Angew Chem Int Ed Engl       Date:  2012-10-12       Impact factor: 15.336

10.  Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin.

Authors:  Tom N Grossmann; Johannes T-H Yeh; Brian R Bowman; Qian Chu; Raymond E Moellering; Gregory L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.